nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—RARA—amyotrophic lateral sclerosis	0.634	1	CbGaD
Alitretinoin—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.114	1	CbGbCtD
Alitretinoin—CRABP1—hindbrain—amyotrophic lateral sclerosis	0.00383	0.0828	CbGeAlD
Alitretinoin—RARG—tongue—amyotrophic lateral sclerosis	0.0033	0.0712	CbGeAlD
Alitretinoin—Cardiac murmur—Riluzole—amyotrophic lateral sclerosis	0.0029	0.0235	CcSEcCtD
Alitretinoin—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0229	CcSEcCtD
Alitretinoin—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.00252	0.0204	CcSEcCtD
Alitretinoin—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00252	0.0204	CcSEcCtD
Alitretinoin—CRABP1—embryo—amyotrophic lateral sclerosis	0.0024	0.0518	CbGeAlD
Alitretinoin—Isotretinoin—RARA—amyotrophic lateral sclerosis	0.0024	0.412	CrCbGaD
Alitretinoin—CRABP1—brainstem—amyotrophic lateral sclerosis	0.0022	0.0474	CbGeAlD
Alitretinoin—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0177	CcSEcCtD
Alitretinoin—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0177	CcSEcCtD
Alitretinoin—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0177	CcSEcCtD
Alitretinoin—CRABP2—embryo—amyotrophic lateral sclerosis	0.00217	0.0468	CbGeAlD
Alitretinoin—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0171	CcSEcCtD
Alitretinoin—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0168	CcSEcCtD
Alitretinoin—Acitretin—RARA—amyotrophic lateral sclerosis	0.00204	0.351	CrCbGaD
Alitretinoin—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0153	CcSEcCtD
Alitretinoin—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0146	CcSEcCtD
Alitretinoin—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00162	0.0132	CcSEcCtD
Alitretinoin—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.0016	0.013	CcSEcCtD
Alitretinoin—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.0016	0.013	CcSEcCtD
Alitretinoin—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0128	CcSEcCtD
Alitretinoin—CRABP1—medulla oblongata—amyotrophic lateral sclerosis	0.00153	0.0331	CbGeAlD
Alitretinoin—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00153	0.0124	CcSEcCtD
Alitretinoin—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00146	0.0118	CcSEcCtD
Alitretinoin—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0115	CcSEcCtD
Alitretinoin—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0115	CcSEcCtD
Alitretinoin—Embolism—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0113	CcSEcCtD
Alitretinoin—CRABP2—medulla oblongata—amyotrophic lateral sclerosis	0.00138	0.0299	CbGeAlD
Alitretinoin—Tretinoin—RARA—amyotrophic lateral sclerosis	0.00138	0.237	CrCbGaD
Alitretinoin—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0111	CcSEcCtD
Alitretinoin—CRABP1—spinal cord—amyotrophic lateral sclerosis	0.00137	0.0295	CbGeAlD
Alitretinoin—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0107	CcSEcCtD
Alitretinoin—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0106	CcSEcCtD
Alitretinoin—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0105	CcSEcCtD
Alitretinoin—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0103	CcSEcCtD
Alitretinoin—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0103	CcSEcCtD
Alitretinoin—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0103	CcSEcCtD
Alitretinoin—CRABP2—spinal cord—amyotrophic lateral sclerosis	0.00123	0.0267	CbGeAlD
Alitretinoin—RXRG—medulla oblongata—amyotrophic lateral sclerosis	0.00121	0.0262	CbGeAlD
Alitretinoin—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00951	CcSEcCtD
Alitretinoin—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00935	CcSEcCtD
Alitretinoin—CRABP1—nervous system—amyotrophic lateral sclerosis	0.00115	0.0249	CbGeAlD
Alitretinoin—CRABP1—central nervous system—amyotrophic lateral sclerosis	0.00111	0.0239	CbGeAlD
Alitretinoin—CRABP1—cerebellum—amyotrophic lateral sclerosis	0.00108	0.0234	CbGeAlD
Alitretinoin—RXRG—spinal cord—amyotrophic lateral sclerosis	0.00108	0.0233	CbGeAlD
Alitretinoin—CRABP2—nervous system—amyotrophic lateral sclerosis	0.00104	0.0225	CbGeAlD
Alitretinoin—RXRA—nervous system—amyotrophic lateral sclerosis	0.00104	0.0224	CbGeAlD
Alitretinoin—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.001	0.00812	CcSEcCtD
Alitretinoin—CRABP2—central nervous system—amyotrophic lateral sclerosis	0.001	0.0216	CbGeAlD
Alitretinoin—RXRA—central nervous system—amyotrophic lateral sclerosis	0.000997	0.0215	CbGeAlD
Alitretinoin—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.000989	0.00801	CcSEcCtD
Alitretinoin—CRABP2—cerebellum—amyotrophic lateral sclerosis	0.000979	0.0212	CbGeAlD
Alitretinoin—Gout—Riluzole—amyotrophic lateral sclerosis	0.000963	0.0078	CcSEcCtD
Alitretinoin—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.000957	0.00775	CcSEcCtD
Alitretinoin—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.000951	0.0077	CcSEcCtD
Alitretinoin—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.000951	0.0077	CcSEcCtD
Alitretinoin—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.000951	0.0077	CcSEcCtD
Alitretinoin—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.000951	0.0077	CcSEcCtD
Alitretinoin—Cataract—Riluzole—amyotrophic lateral sclerosis	0.000945	0.00765	CcSEcCtD
Alitretinoin—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.000922	0.00746	CcSEcCtD
Alitretinoin—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.000916	0.00741	CcSEcCtD
Alitretinoin—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00091	0.00737	CcSEcCtD
Alitretinoin—RXRG—nervous system—amyotrophic lateral sclerosis	0.000909	0.0196	CbGeAlD
Alitretinoin—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0009	0.00728	CcSEcCtD
Alitretinoin—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0009	0.00728	CcSEcCtD
Alitretinoin—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.000894	0.00724	CcSEcCtD
Alitretinoin—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.000889	0.0072	CcSEcCtD
Alitretinoin—CRABP1—brain—amyotrophic lateral sclerosis	0.000879	0.019	CbGeAlD
Alitretinoin—RARB—cerebellum—amyotrophic lateral sclerosis	0.000876	0.0189	CbGeAlD
Alitretinoin—RXRG—central nervous system—amyotrophic lateral sclerosis	0.000876	0.0189	CbGeAlD
Alitretinoin—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000869	0.00703	CcSEcCtD
Alitretinoin—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.000859	0.00695	CcSEcCtD
Alitretinoin—RXRB—nervous system—amyotrophic lateral sclerosis	0.000855	0.0185	CbGeAlD
Alitretinoin—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.000845	0.00684	CcSEcCtD
Alitretinoin—RXRB—central nervous system—amyotrophic lateral sclerosis	0.000823	0.0178	CbGeAlD
Alitretinoin—Coma—Riluzole—amyotrophic lateral sclerosis	0.000822	0.00665	CcSEcCtD
Alitretinoin—RXRB—cerebellum—amyotrophic lateral sclerosis	0.000805	0.0174	CbGeAlD
Alitretinoin—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.000801	0.00648	CcSEcCtD
Alitretinoin—CRABP2—brain—amyotrophic lateral sclerosis	0.000795	0.0172	CbGeAlD
Alitretinoin—RXRA—brain—amyotrophic lateral sclerosis	0.000792	0.0171	CbGeAlD
Alitretinoin—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.000781	0.00632	CcSEcCtD
Alitretinoin—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.000773	0.00626	CcSEcCtD
Alitretinoin—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.000765	0.00619	CcSEcCtD
Alitretinoin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.000765	0.00619	CcSEcCtD
Alitretinoin—RARG—nervous system—amyotrophic lateral sclerosis	0.000759	0.0164	CbGeAlD
Alitretinoin—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.000758	0.00613	CcSEcCtD
Alitretinoin—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.000751	0.00608	CcSEcCtD
Alitretinoin—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.000751	0.00608	CcSEcCtD
Alitretinoin—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.000744	0.00602	CcSEcCtD
Alitretinoin—RARG—central nervous system—amyotrophic lateral sclerosis	0.000731	0.0158	CbGeAlD
Alitretinoin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00591	CcSEcCtD
Alitretinoin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.000727	0.00588	CcSEcCtD
Alitretinoin—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00072	0.00583	CcSEcCtD
Alitretinoin—RARG—cerebellum—amyotrophic lateral sclerosis	0.000714	0.0154	CbGeAlD
Alitretinoin—RARA—nervous system—amyotrophic lateral sclerosis	0.000714	0.0154	CbGeAlD
Alitretinoin—RARB—brain—amyotrophic lateral sclerosis	0.000711	0.0154	CbGeAlD
Alitretinoin—RXRG—brain—amyotrophic lateral sclerosis	0.000695	0.015	CbGeAlD
Alitretinoin—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.000692	0.0056	CcSEcCtD
Alitretinoin—RARA—central nervous system—amyotrophic lateral sclerosis	0.000687	0.0148	CbGeAlD
Alitretinoin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000672	0.00544	CcSEcCtD
Alitretinoin—RARA—cerebellum—amyotrophic lateral sclerosis	0.000672	0.0145	CbGeAlD
Alitretinoin—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000669	0.00542	CcSEcCtD
Alitretinoin—RXRB—brain—amyotrophic lateral sclerosis	0.000654	0.0141	CbGeAlD
Alitretinoin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000653	0.00529	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000653	0.00529	CcSEcCtD
Alitretinoin—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000643	0.0052	CcSEcCtD
Alitretinoin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000638	0.00516	CcSEcCtD
Alitretinoin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00063	0.0051	CcSEcCtD
Alitretinoin—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000621	0.00503	CcSEcCtD
Alitretinoin—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000619	0.00501	CcSEcCtD
Alitretinoin—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000607	0.00492	CcSEcCtD
Alitretinoin—RARG—brain—amyotrophic lateral sclerosis	0.00058	0.0125	CbGeAlD
Alitretinoin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000578	0.00468	CcSEcCtD
Alitretinoin—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000568	0.0046	CcSEcCtD
Alitretinoin—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000564	0.00457	CcSEcCtD
Alitretinoin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000564	0.00457	CcSEcCtD
Alitretinoin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000553	0.00448	CcSEcCtD
Alitretinoin—RARA—brain—amyotrophic lateral sclerosis	0.000545	0.0118	CbGeAlD
Alitretinoin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000541	0.00438	CcSEcCtD
Alitretinoin—RXRA—Organelle biogenesis and maintenance—GFM1—amyotrophic lateral sclerosis	0.000534	0.00695	CbGpPWpGaD
Alitretinoin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000528	0.00427	CcSEcCtD
Alitretinoin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000528	0.00427	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000526	0.00685	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000526	0.00685	CbGpPWpGaD
Alitretinoin—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000521	0.00422	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000515	0.00417	CcSEcCtD
Alitretinoin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000514	0.00416	CcSEcCtD
Alitretinoin—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000511	0.00413	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000511	0.00665	CbGpPWpGaD
Alitretinoin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000506	0.0041	CcSEcCtD
Alitretinoin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000503	0.00407	CcSEcCtD
Alitretinoin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000503	0.00407	CcSEcCtD
Alitretinoin—Depression—Riluzole—amyotrophic lateral sclerosis	0.000502	0.00406	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000501	0.00652	CbGpPWpGaD
Alitretinoin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000496	0.00402	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00399	CcSEcCtD
Alitretinoin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00399	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000492	0.00641	CbGpPWpGaD
Alitretinoin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00049	0.00397	CcSEcCtD
Alitretinoin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000489	0.00396	CcSEcCtD
Alitretinoin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000482	0.0039	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000481	0.00627	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000481	0.00627	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00048	0.00625	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00048	0.00625	CbGpPWpGaD
Alitretinoin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00048	0.00388	CcSEcCtD
Alitretinoin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000475	0.00384	CcSEcCtD
Alitretinoin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000472	0.00382	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000472	0.00614	CbGpPWpGaD
Alitretinoin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00047	0.0038	CcSEcCtD
Alitretinoin—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000454	0.00367	CcSEcCtD
Alitretinoin—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000452	0.00366	CcSEcCtD
Alitretinoin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000452	0.00366	CcSEcCtD
Alitretinoin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000449	0.00364	CcSEcCtD
Alitretinoin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000449	0.00364	CcSEcCtD
Alitretinoin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00363	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000448	0.00583	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000448	0.00583	CbGpPWpGaD
Alitretinoin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000446	0.00361	CcSEcCtD
Alitretinoin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000445	0.0036	CcSEcCtD
Alitretinoin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000443	0.00358	CcSEcCtD
Alitretinoin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000427	0.00346	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000423	0.00551	CbGpPWpGaD
Alitretinoin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000422	0.00342	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000421	0.00548	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000421	0.00548	CbGpPWpGaD
Alitretinoin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00041	0.00332	CcSEcCtD
Alitretinoin—Chills—Riluzole—amyotrophic lateral sclerosis	0.000405	0.00328	CcSEcCtD
Alitretinoin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000404	0.00327	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000401	0.00522	CbGpPWpGaD
Alitretinoin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000399	0.00323	CcSEcCtD
Alitretinoin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000396	0.0032	CcSEcCtD
Alitretinoin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000393	0.00318	CcSEcCtD
Alitretinoin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000387	0.00314	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000387	0.00504	CbGpPWpGaD
Alitretinoin—Tension—Riluzole—amyotrophic lateral sclerosis	0.000386	0.00312	CcSEcCtD
Alitretinoin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000382	0.00309	CcSEcCtD
Alitretinoin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00038	0.00308	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000379	0.00494	CbGpPWpGaD
Alitretinoin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000368	0.00298	CcSEcCtD
Alitretinoin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000365	0.00295	CcSEcCtD
Alitretinoin—RXRB—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000364	0.00474	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000364	0.00474	CbGpPWpGaD
Alitretinoin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000363	0.00294	CcSEcCtD
Alitretinoin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000361	0.00293	CcSEcCtD
Alitretinoin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000355	0.00287	CcSEcCtD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000354	0.00461	CbGpPWpGaD
Alitretinoin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000353	0.00285	CcSEcCtD
Alitretinoin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000348	0.00281	CcSEcCtD
Alitretinoin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000346	0.0028	CcSEcCtD
Alitretinoin—Cough—Riluzole—amyotrophic lateral sclerosis	0.000343	0.00278	CcSEcCtD
Alitretinoin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000341	0.00276	CcSEcCtD
Alitretinoin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00034	0.00275	CcSEcCtD
Alitretinoin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000335	0.00271	CcSEcCtD
Alitretinoin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000335	0.00271	CcSEcCtD
Alitretinoin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000335	0.00271	CcSEcCtD
Alitretinoin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000334	0.0027	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000332	0.00269	CcSEcCtD
Alitretinoin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000331	0.00268	CcSEcCtD
Alitretinoin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000327	0.00265	CcSEcCtD
Alitretinoin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000324	0.00262	CcSEcCtD
Alitretinoin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000321	0.0026	CcSEcCtD
Alitretinoin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000321	0.0026	CcSEcCtD
Alitretinoin—Infection—Riluzole—amyotrophic lateral sclerosis	0.000319	0.00258	CcSEcCtD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000319	0.00415	CbGpPWpGaD
Alitretinoin—Shock—Riluzole—amyotrophic lateral sclerosis	0.000316	0.00256	CcSEcCtD
Alitretinoin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000315	0.00255	CcSEcCtD
Alitretinoin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000314	0.00254	CcSEcCtD
Alitretinoin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000313	0.00254	CcSEcCtD
Alitretinoin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000312	0.00252	CcSEcCtD
Alitretinoin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00031	0.00251	CcSEcCtD
Alitretinoin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000306	0.00248	CcSEcCtD
Alitretinoin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0003	0.00243	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000292	0.00237	CcSEcCtD
Alitretinoin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00029	0.00235	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000288	0.00376	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000288	0.00376	CbGpPWpGaD
Alitretinoin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000288	0.00233	CcSEcCtD
Alitretinoin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000286	0.00232	CcSEcCtD
Alitretinoin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000285	0.00231	CcSEcCtD
Alitretinoin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000283	0.00229	CcSEcCtD
Alitretinoin—ABCB1—embryo—amyotrophic lateral sclerosis	0.000282	0.0061	CbGeAlD
Alitretinoin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000279	0.00226	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000277	0.00224	CcSEcCtD
Alitretinoin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000277	0.00224	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000276	0.00359	CbGpPWpGaD
Alitretinoin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000274	0.00222	CcSEcCtD
Alitretinoin—Pain—Riluzole—amyotrophic lateral sclerosis	0.000274	0.00222	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.000273	0.00355	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000269	0.0035	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000268	0.00349	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000265	0.00344	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000264	0.00214	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000262	0.00212	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000257	0.00334	CbGpPWpGaD
Alitretinoin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000255	0.00206	CcSEcCtD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000254	0.00331	CbGpPWpGaD
Alitretinoin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000254	0.00205	CcSEcCtD
Alitretinoin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000254	0.00205	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000252	0.00328	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00025	0.00326	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000246	0.0032	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000246	0.0032	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000242	0.00315	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000241	0.00314	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000239	0.00311	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000236	0.00191	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000234	0.00305	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000234	0.00305	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000234	0.00305	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000234	0.00305	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000231	0.00301	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000231	0.00301	CbGpPWpGaD
Alitretinoin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00023	0.00186	CcSEcCtD
Alitretinoin—RARG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000229	0.00298	CbGpPWpGaD
Alitretinoin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000227	0.00184	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000222	0.00289	CbGpPWpGaD
Alitretinoin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00022	0.00178	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000219	0.00285	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000219	0.00285	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000214	0.00279	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000214	0.00279	CbGpPWpGaD
Alitretinoin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000212	0.00172	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000209	0.00272	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000205	0.00267	CbGpPWpGaD
Alitretinoin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000204	0.00165	CcSEcCtD
Alitretinoin—RARG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000204	0.00265	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000203	0.00265	CbGpPWpGaD
Alitretinoin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000202	0.00164	CcSEcCtD
Alitretinoin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000202	0.00164	CcSEcCtD
Alitretinoin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000201	0.00163	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.0002	0.00261	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000199	0.0026	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000199	0.0026	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000199	0.00259	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000196	0.00256	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000196	0.00256	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000195	0.00253	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000191	0.00249	CbGpPWpGaD
Alitretinoin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000191	0.00154	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00019	0.00247	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000187	0.00244	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000187	0.00244	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000187	0.00243	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000186	0.00243	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000183	0.00238	CbGpPWpGaD
Alitretinoin—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00018	0.0039	CbGeAlD
Alitretinoin—RARA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000175	0.00228	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000175	0.00228	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000175	0.00228	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00017	0.00221	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00017	0.00221	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000164	0.00214	CbGpPWpGaD
Alitretinoin—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000161	0.00348	CbGeAlD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000159	0.00207	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000157	0.00205	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000157	0.00204	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00015	0.00196	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000148	0.00192	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000146	0.0019	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000141	0.00184	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000139	0.00181	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000138	0.00179	CbGpPWpGaD
Alitretinoin—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000136	0.00293	CbGeAlD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000136	0.00176	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000135	0.00176	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000134	0.00174	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000131	0.00171	CbGpPWpGaD
Alitretinoin—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000131	0.00282	CbGeAlD
Alitretinoin—RXRG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000129	0.00168	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000128	0.00167	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000128	0.00167	CbGpPWpGaD
Alitretinoin—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000128	0.00276	CbGeAlD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000127	0.00166	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000127	0.00165	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000127	0.00165	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000126	0.00164	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000121	0.00158	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000121	0.00158	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00012	0.00157	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.00012	0.00156	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000119	0.00154	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000119	0.00154	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000118	0.00153	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000116	0.00151	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000115	0.0015	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000114	0.00148	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000113	0.00147	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000113	0.00147	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000109	0.00142	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000109	0.00142	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000108	0.00141	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000108	0.00141	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000107	0.00139	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000106	0.00139	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000106	0.00137	CbGpPWpGaD
Alitretinoin—ABCB1—brain—amyotrophic lateral sclerosis	0.000104	0.00224	CbGeAlD
Alitretinoin—RXRA—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000102	0.00133	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000102	0.00133	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	9.96e-05	0.0013	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	9.83e-05	0.00128	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—RARA—amyotrophic lateral sclerosis	9.79e-05	0.00127	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.74e-05	0.00127	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CHAT—amyotrophic lateral sclerosis	9.74e-05	0.00127	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	9.73e-05	0.00127	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—RARA—amyotrophic lateral sclerosis	9.6e-05	0.00125	CbGpPWpGaD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	9.28e-05	0.00121	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.26e-05	0.00121	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—RARA—amyotrophic lateral sclerosis	9.2e-05	0.0012	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	9.13e-05	0.00119	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.88e-05	0.00116	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.88e-05	0.00116	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	8.83e-05	0.00115	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.73e-05	0.00114	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	8.47e-05	0.0011	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PFN1—amyotrophic lateral sclerosis	8.44e-05	0.0011	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	8.2e-05	0.00107	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	8.2e-05	0.00107	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	8.01e-05	0.00104	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	7.88e-05	0.00103	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	7.86e-05	0.00102	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	7.83e-05	0.00102	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.4e-05	0.000963	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.3e-05	0.00095	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IGF1—amyotrophic lateral sclerosis	7.24e-05	0.000943	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—VAPB—amyotrophic lateral sclerosis	7.1e-05	0.000924	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TPK1—amyotrophic lateral sclerosis	7.1e-05	0.000924	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	6.96e-05	0.000906	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	6.67e-05	0.000868	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.62e-05	0.000862	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.6e-05	0.00086	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—VAPA—amyotrophic lateral sclerosis	6.49e-05	0.000845	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	6.34e-05	0.000825	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	6.33e-05	0.000824	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.29e-05	0.000819	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.29e-05	0.000819	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.09e-05	0.000792	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.09e-05	0.000792	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.03e-05	0.000786	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—FUS—amyotrophic lateral sclerosis	5.88e-05	0.000766	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	5.7e-05	0.000742	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—FIG4—amyotrophic lateral sclerosis	5.67e-05	0.000739	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.61e-05	0.00073	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	5.6e-05	0.000729	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	5.51e-05	0.000717	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	5.35e-05	0.000696	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	5.32e-05	0.000693	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.26e-05	0.000684	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.23e-05	0.000681	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.23e-05	0.000681	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—DAO—amyotrophic lateral sclerosis	5.13e-05	0.000668	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.08e-05	0.000662	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	5.05e-05	0.000658	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.04e-05	0.000656	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	5.03e-05	0.000655	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.81e-05	0.000626	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.81e-05	0.000626	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—RARA—amyotrophic lateral sclerosis	4.79e-05	0.000624	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.65e-05	0.000605	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	4.59e-05	0.000598	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	4.41e-05	0.000574	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	4.4e-05	0.000572	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.32e-05	0.000563	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.11e-05	0.000535	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	4.1e-05	0.000533	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.06e-05	0.000529	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—APOE—amyotrophic lateral sclerosis	3.96e-05	0.000515	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—APOE—amyotrophic lateral sclerosis	3.96e-05	0.000515	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PLB1—amyotrophic lateral sclerosis	3.89e-05	0.000506	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	3.89e-05	0.000506	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSR—amyotrophic lateral sclerosis	3.59e-05	0.000467	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.48e-05	0.000453	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.46e-05	0.000451	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	3.32e-05	0.000432	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.28e-05	0.000427	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.27e-05	0.000426	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	3.25e-05	0.000423	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	3.13e-05	0.000407	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.96e-05	0.000385	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.95e-05	0.000385	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CHAT—amyotrophic lateral sclerosis	2.95e-05	0.000384	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.91e-05	0.000379	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.84e-05	0.000369	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.84e-05	0.000369	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.81e-05	0.000366	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.79e-05	0.000363	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.71e-05	0.000353	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.71e-05	0.000353	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.69e-05	0.00035	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.63e-05	0.000342	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.59e-05	0.000338	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.51e-05	0.000327	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.51e-05	0.000327	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.41e-05	0.000314	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.27e-05	0.000295	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.26e-05	0.000295	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.26e-05	0.000295	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.24e-05	0.000292	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.13e-05	0.000277	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.11e-05	0.000275	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.07e-05	0.00027	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.05e-05	0.000267	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.93e-05	0.000251	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.84e-05	0.00024	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.81e-05	0.000236	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—amyotrophic lateral sclerosis	1.81e-05	0.000236	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.76e-05	0.00023	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.64e-05	0.000213	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.64e-05	0.000213	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.63e-05	0.000212	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.58e-05	0.000206	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.55e-05	0.000202	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.46e-05	0.00019	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.43e-05	0.000187	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.39e-05	0.000181	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.24e-05	0.000162	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOE—amyotrophic lateral sclerosis	1.2e-05	0.000156	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.18e-05	0.000153	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.14e-05	0.000149	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.05e-05	0.000137	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	0.000136	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	9.4e-06	0.000122	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.58e-06	0.000112	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.21e-06	0.000107	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.33e-06	8.24e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.88e-06	7.65e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.82e-06	7.57e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.05e-06	6.58e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	4.79e-06	6.23e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.64e-06	6.05e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.82e-06	4.97e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.28e-06	4.27e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.62e-06	3.41e-05	CbGpPWpGaD
